HealthEquity, Inc. (HQY) Stock Price & How to Invest
Last updated November 2026
Short answer
HealthEquity (HQY) is the biggest independent custodian of US health savings accounts, earning fees on 17.8 million benefit accounts (as of April 2026), an interest spread on about $17.5 billion of member cash, and interchange on card spending. Anyone can own it as a single Nasdaq-listed stock, or hold it as one position in a group built around benefits administration and rate-sensitive fee businesses. As of October 16, 2026 the stock closed near $92, roughly flat for the year, with a market cap around $7.7 billion.
HQY stock price
As of 2026-11-16, HealthEquity, Inc. (HQY) last closed at $104.58, up 4.4% over the past year. Over the past 52 weeks it has traded between $73.21 and $108.84.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or HealthEquity, Inc.'s investor relations page. Walnut is informational, not investment advice.
HQY key stats
At $104.58 on November 16, 2026, HealthEquity, Inc. (HQY) has a market cap of $8.7B and a P/E of 37.8 on trailing earnings (19.0 on forward earnings). It next reports earnings on December 1, 2026.
- Market cap
- $8.7B
- P/E (trailing)
- 37.8
- P/E (forward)
- 19.0
- EPS (trailing 12 months)
- $2.77
- Price to book
- 4.4
- Beta
- 0.19
- Next earnings
- December 1, 2026
Market cap, P/E and yield are measured at the $104.58 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.
What's new with HealthEquity, Inc. (HQY)?
The last two weeks for HealthEquity, Inc., as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.
- HQY closed at $104.58 on November 16, 2026, up 2.4% over the past five trading days (from $102.11).
- HealthEquity, Inc. next reports quarterly results on December 1, 2026.
HealthEquity, Inc. filed no current, quarterly or annual report with the SEC in the last two weeks.
Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.
HealthEquity, Inc. (HQY) latest quarter
HealthEquity reported revenue of $351 million for Q2 fiscal 2027, up 8% from a year earlier (HealthEquity, Aug 27, 2026).
Source: HealthEquity Q2 fiscal 2027 results, Aug 27, 2026. Full earnings breakdown
What does HealthEquity, Inc. (HQY) do?
HealthEquity, Inc. is the largest independent non-bank custodian of health savings accounts in the United States, and it also administers the flexible spending accounts, health reimbursement arrangements, COBRA and commuter benefits that sit alongside them. As of April 30, 2026 it held 10.6 million HSAs containing $37.1 billion of member assets, plus 7.2 million other consumer-directed benefit accounts, for 17.8 million total accounts. Almost none of that comes from consumers directly: it reaches members through their employers, and employers through benefits brokers, health plans and retirement recordkeepers. Revenue arrives in three lines: service fees from employers and members, custodial revenue on the interest spread from member cash placed with insurance-company partners and banks, and interchange on every swipe of a member's benefits card. Custodial is the biggest and by far the most profitable, at $174.3 million of the $354.6 million booked in the quarter ended April 30, 2026, against only $11.7 million of direct cost.
The investment question is really about interest rates and where member money sits. Account growth is steady rather than exciting (HSAs up 8% year over year, total accounts up 4%, other benefit accounts flat), so earnings power comes from balances compounding and from old low-rate cash contracts rolling into better ones. HealthEquity disclosed that $16.5 billion of contracted HSA cash earned an average annualized 3.6% at the end of April 2026, with $3.2 billion of it still at 1.8% and due to reprice before the fiscal year ends. Members are also moving cash into markets: invested HSA balances reached $19.6 billion, up 38%, while HSA cash grew just 3%. In May, management raised fiscal 2027 guidance to roughly $1.41 billion to $1.42 billion of revenue and $625 million to $633 million of adjusted EBITDA.
The second quarter of fiscal 2027 (ended July 31, 2026, reported August 27) brought revenue of about $350.7 million, up 7.6% year over year, net income of about $65.6 million and adjusted EPS of $1.24, ahead of the $1.19 consensus. Management nudged revenue guidance up only slightly, to $1.411 billion to $1.421 billion, and reiterated adjusted EPS guidance of $4.66 to $4.73; the shares fell 8.6% that week on the modest outlook. In October the company terminated its chief commercial officer, Michael Fiore. About $7.7 billion of market value against $1.36 billion of trailing revenue still leaves little slack if the repricing tailwind fades or if service revenue, up only 3% in the April quarter, keeps decelerating.
What's driving HealthEquity, Inc. (HQY)?
1. The cash repricing ladder
HealthEquity locks member cash into multi-year contracts with insurance companies and banks, so its yield moves in slow motion rather than with the Fed. At April 30, 2026, $16.5 billion of contracted HSA cash carried an average annualized yield of 3.6%, and the $3.2 billion repricing in the rest of fiscal 2027 was still earning only 1.8%. Custodial revenue rose 11% to $174.3 million in the April 2026 quarter on that mechanic alone, with barely any cost attached.
2. Balances that compound whether or not accounts do
Invested HSA balances hit $19.6 billion, up 38% year over year, and 909,000 accounts now hold investments versus 770,000 a year earlier. HealthEquity charges on invested assets through its service line, so market appreciation and the drift from cash into funds both feed revenue. But money leaving cash for funds also shrinks the custodial base, which is the higher-margin pool.
3. Cost discipline and shrinking the share count
Service costs fell 11% year over year to $78.3 million even as accounts grew, which is where most of the operating leverage in the quarter came from. Gross margin reached 72% that quarter and net income rose 29% to $69.4 million. The company also retired 1.5 million shares for roughly $123.0 million during the quarter, leaving about 83.8 million outstanding. Over the trailing twelve months to July 2026, gross margin was about 71%, operating margin about 28% and net income about $236 million.
4. Policy and the structural HSA tailwind
High-deductible plan enrollment is what creates new HSAs, and Washington has repeatedly widened eligibility rather than narrowed it. HealthEquity opened about 172,000 new accounts from sales in the April 2026 quarter, up 15% from a year earlier. Any legislative expansion of who may fund an HSA lands directly in the account funnel, and any contraction works the same way in reverse.
What are the risks to HealthEquity, Inc. (HQY)?
Custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived. Service revenue grew only 3% in the April 2026 quarter and average service fees per account are falling, which means growth in accounts is not translating cleanly into growth in fees. Competition for the employer default slot is intense, with Optum Bank, Fidelity and HSA Bank all able to undercut on price, and Fidelity in particular markets a no-fee individual HSA. A fiscal 2025 cybersecurity incident involving a business partner's compromised user account left the company facing a consolidated putative consumer class action in federal court in the District of Utah, where it filed a renewed motion to compel arbitration on May 15, 2026, plus several regulatory inquiries; separately, several plaintiff firms have publicized securities investigations following the March 2025 guidance reaction, though the latest 10-Q discloses no pending securities fraud case. Complementary benefit accounts (FSA, HRA, COBRA, commuter) were flat at 7.2 million, so the non-HSA half of the account base is not currently contributing growth. Leadership turnover is a newer watch point: the company terminated Chief Commercial Officer Michael Fiore in October 2026, a role tied directly to winning employer and partner accounts.
What is the HealthEquity, Inc. (HQY) forecast?
15 analysts publish price targets on HQY, averaging $120.67 as of November 2026, or +15.4% against the $104.58 share price on November 16, 2026. The published targets run from $108.00 to $142.00, a narrow spread, and the ratings split 15 buy, 0 hold, 0 sell. Over the last six months there have been 6 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.
Read the full HQY forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.
Is HQY a buy or a sell?
We give no verdict on HealthEquity, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.
The case for buying. The cash repricing ladder. HealthEquity locks member cash into multi-year contracts with insurance companies and banks, so its yield moves in slow motion rather than with the Fed. The most optimistic published target, $142.00, assumes this works close to its best case.
The case against. Custodial revenue is the profit engine and it depends on rates HealthEquity does not control, so a sustained decline in market yields would eventually reset renewing contracts lower, just as slowly as the current tailwind arrived. The most pessimistic target, $108.00, is roughly what HQY is worth if this bites instead.
Read the full bull and bear case on HQY, including what would have to change to break either one. Walnut is not an investment adviser.
Has HealthEquity, Inc. (HQY) split its stock?
No. HealthEquity, Inc. (HQY) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.
How is HealthEquity, Inc. (HQY) valued?
Market cap, P/E and dividend yield at today's price are in the HQY key stats above. The business figures below come from HealthEquity, Inc.'s reported results as of October 2026 and change when it next reports.
- Revenue (TTM): ~$1.36B
- Latest quarter (Q2 FY2027, ended July 31, 2026): ~$350.7M revenue, +7.6% year over year
- Q2 FY2027 earnings: ~$65.6M net income, ~$1.24 adjusted EPS (vs ~$1.19 expected)
- Margins (TTM): ~71% gross, ~28% operating
- Fiscal 2027 guidance: ~$1.411B to ~$1.421B revenue, ~$4.66 to ~$4.73 adjusted EPS
As of October 2026: HealthEquity runs a January fiscal year, so the quarter ended July 31, 2026 is fiscal 2027's second. At about $92 on October 16, 2026 the stock traded near 34x trailing GAAP earnings and about 17x forward estimates, with EV/EBITDA near 16x; debt of about $971 million against $256 million of cash keeps leverage modest. Because custodial revenue carries almost no direct cost, small changes in the yield on member cash swing earnings far more than equivalent changes in account count.
Who competes with HealthEquity, Inc. (HQY)?
Rival HSA custodians
Optum Bank, part of UnitedHealth Group (UNH), is the other giant and comes bundled with a health plan. HSA Bank, owned by Webster Financial (WBS), and Bank of America hold HSA cash on their own balance sheets, which gives them a different economic model. Fidelity has grown fast by offering an individual HSA with no account fee, and Lively and Inspira Financial compete at the smaller end.
Consumer-directed benefits administrators
The FSA, HRA, COBRA and commuter half of HealthEquity's book is contested by WEX Inc. (WEX), whose benefits segment does the same work with a payments heritage, Alight Solutions (ALIT), and the benefits administration arms of ADP, Paychex and TriNet. These deals are usually won or lost with the employer's HR and payroll decision, not with the individual employee.
Where invested HSA dollars actually go
Once a member moves cash into funds, the fee conversation is with asset managers. Vanguard, Fidelity and Charles Schwab (SCHW) set the expectation that fund expenses should be near zero, which caps what a custodian can charge on invested balances and pressures the service line over time.
What stocks are similar to HealthEquity, Inc. (HQY)?
Other names that sit close to HQY: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.
How to invest in HealthEquity, Inc. (HQY)
There are three common ways to get HQY exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so HQY sits alongside other stocks that express the same thesis.
Walnut takes the portfolio route. Describe a thesis where HQY fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on HealthEquity, Inc. (HQY)
HQY is a fee-and-spread business on America's HSA balances, so its earnings track account growth and, much more powerfully, the yield it can renew on member cash. The latest quarter beat estimates, but a barely raised outlook left the shares about where they started 2026.
More on HealthEquity, Inc. (HQY)
Whether HQY is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is HQY a buy or a sell?, and where the stock could go from here in the HQY stock forecast.
For income investors, whether HQY pays a dividend and how the payout looks is covered in does HQY pay a dividend? And to weigh HQY against a peer, read the full side-by-side comparisons: HQY vs UNH and HQY vs WBS.
Wondering how HQY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about HealthEquity, Inc.
Ask Walnut's AI anything about HQY and see how it fits what you own.
FAQ
What does HealthEquity actually do?
+
It is the custodian and administrator behind health savings accounts and related workplace benefit accounts. HealthEquity holds the money, runs the account and the payment card, handles claims substantiation for FSAs and HRAs, and administers COBRA and commuter benefits. As of April 30, 2026 it looked after 10.6 million HSAs and 7.2 million other accounts, 17.8 million in total, for employers across the United States.
How does HealthEquity make money?
+
Three ways. Service revenue is per-account administration fees paid by employers, health plans and members, plus fees on invested balances and its marketplace. Custodial revenue is the spread it keeps on member cash placed with insurance-company partners and banks. Interchange revenue comes from merchants each time a member swipes a benefits card. In the April 2026 quarter those lines were $122.9 million, $174.3 million and $57.4 million.
What is the full legal name of the company that trades as HQY?
+
HealthEquity, Inc., a Delaware corporation headquartered at 15 West Scenic Pointe Drive in Draper, Utah. Its shares trade on the Nasdaq Global Select Market under the ticker HQY, and it files with the SEC under CIK 1428336 and commission file number 001-36568. Its fiscal year ends on January 31, so fiscal 2027 covers February 2026 through January 2027.
What did HealthEquity report most recently?
+
Second quarter fiscal 2027, the three months ended July 31, 2026, reported on August 27, 2026. Revenue of $350.7 million was up 7.6%, net income was about $65.6 million, and adjusted EPS of $1.24 beat the $1.19 consensus. Management narrowly raised full-year revenue guidance to $1.411 billion to $1.421 billion and reiterated adjusted EPS guidance of $4.66 to $4.73. The prior quarter (ended April 30) had revenue of $354.6 million and net income of $69.4 million, up 29%.
Is HQY expensive at current levels?
+
Around $7.7 billion of market value as of October 16, 2026 works out to roughly 5.6 times trailing revenue, about 34 times trailing GAAP earnings and about 17 times forward estimates, with EV/EBITDA near 16x. Whether that is demanding depends on how much of the cash repricing tailwind is left, since custodial revenue carries almost no direct cost and drops through to profit at a much higher rate than fee revenue. Analysts' mean target was about $119.
Does HealthEquity pay a dividend?
+
No. HealthEquity has never declared a cash dividend on its common stock and returns capital through buybacks instead. It repurchased about 1.5 million shares for roughly $123.0 million in the quarter ended April 30, 2026, leaving about $55.6 million of authorization remaining at that date and roughly 83.8 million shares outstanding. Anyone holding it is relying on price appreciation rather than income.
What are the main risks in owning HQY?
+
Interest rates come first, because a falling yield on renewing HSA cash contracts would reverse the largest source of profit growth. Fee compression is second: service revenue rose only 3% in the April 2026 quarter as average fees per account slipped. Rivals such as Optum Bank and Fidelity can compete on price for the employer default slot. Data breach litigation and regulatory inquiries from the fiscal 2025 incident also remain open. The October 2026 termination of its chief commercial officer adds some leadership uncertainty.
How would someone invest in HealthEquity?
+
HQY is an ordinary Nasdaq-listed common stock, so it is available at any US brokerage, and brokers that support fractional shares accept a dollar amount rather than a whole share. Some people prefer to hold it as one weighted position in a group of benefits and payments businesses, alongside names like WEX or Alight, so a single company's results do not decide the outcome.
How has HQY stock performed in 2026?
+
As of October 16, 2026, HQY closed near $92, up about 1.5% year to date and over one year, and down about 5% over three months. The shares fell 8.6% in the week of the August 27 earnings report because the raised guidance was smaller than hoped, even though the quarter beat. The 52-week range was about $73 to $108.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with HealthEquity, Inc.'s investor relations page or your broker before making investment decisions.